Panorama Dialysis in Deer Park, Washington - Dialysis Center

Panorama Dialysis is a medicare approved dialysis facility center in Deer Park, Washington and it has 5 dialysis stations. It is located in Spokane county at 822 S Main, Deer Park, WA, 99006. You can reach out to the office of Panorama Dialysis at (509) 276-7338. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Panorama Dialysis has the following ownership type - Profit. It was first certified by medicare in April, 2012. The medicare id for this facility is 502567 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NamePanorama Dialysis
Location822 S Main, Deer Park, Washington
No. of Dialysis Stations 5
Medicare ID502567
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts Yes

Contact Information


822 S Main, Deer Park, Washington, 99006
(509) 276-7338

News Archive

The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

Alcohol-based handrubs can improve hygiene in hospitals

Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 1 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Panorama Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1841574746
Doing Business AsInland Northwest Renal Care Group Llc
Address822 S. Main Street Deer Park, Washington, 99006
Phone Number(509) 276-7338

News Archive

The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

Alcohol-based handrubs can improve hygiene in hospitals

Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 1 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data13
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL8

News Archive

The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

Alcohol-based handrubs can improve hygiene in hospitals

Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 1 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center24
    Adult patient months included in Kt/V greater than or equal to 1.2203
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

    The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

    Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

    Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

    SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

    Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

    Alcohol-based handrubs can improve hygiene in hospitals

    Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

    Regeneron antibody cocktail shows promise as potential COVID-19 treatment

    Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

    Read more Medical News

    › Verified 1 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Panorama Dialysis with elevated calcium levels.

Patients with hypercalcemia30
Hypercalcemia patient months265
Patients with Serumphosphor35
Patients with Serumphosphor less than 3.5 mg/dL2
Patients with Serumphosphor from 3.5 to 4.5 mg/dL22
Patients with Serumphosphor from 4.6 to 5.5 mg/dL36
Patients with Serumphosphor from 5.6 to 7 mg/dL35
Patients with Serumphosphor greater than 7 mg/dL6

News Archive

The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

Alcohol-based handrubs can improve hygiene in hospitals

Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 1 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 22
Patient months included in arterial venous fistula and catheter summaries 182
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment64
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer19

News Archive

The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

Alcohol-based handrubs can improve hygiene in hospitals

Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 1 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary22
Hospitalization Rate in facility125.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit334.8
Hospitalization Rate: Lower Confidence Limit51.1

News Archive

The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

Alcohol-based handrubs can improve hygiene in hospitals

Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 1 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Panorama Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility35.8 (As Expected)
Readmission Rate: Upper Confidence Limit59.5
Readmission Rate: Lower Confidence Limit17.3

News Archive

The Brain Institute wins $7.04 million grant to investigate 'neurophilosphy of free will'

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions.

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Capecitabine is a chemotherapy drug used for breast and colorectal Cancer cancer. It can extend survival rate by nearly 10%.

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

Researchers at the Department of Viroscience, Erasmus MC, National Institute for Public Health and the Environment, Amsterdam UMC, and the Weill Medical College of Cornell University studied humoral and cellular immune responses to the wild type SARS-CoV-2, the B.1.1.7 variant (U.K. variant) and the B.1.351 variant (South African variant) in health care workers vaccinated with the BNT162b2 (Pfizer-BioNTech) mRNA vaccine.

Alcohol-based handrubs can improve hygiene in hospitals

Giving health care workers easy access to alcohol-based handrubs can improve hygiene in hospitals, a study published in the Online Open Access journal Critical Care suggests.

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 1 days ago